Skip to main content

Advertisement

Table 1 Baseline characteristics of 40 HIV-infected patients

From: Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure

Baseline characteristics Number (%), n = 40
Demographics  
Age, mean ± SD, years 37.1 ± 8.0
Male gender, number (%) 28 (70)
Body weight, mean ± SD, Kilograms 57 ± 21
Body mass index, mean ± SD 22.7 ± 4.6
Duration of previous ART, median (IQR), years 2.1 (0.8-3.2)
Laboratory parameters  
CD4 cell counts at virological failure, mean ± SD, cells/mm3 144 ± 124
Percentage of CD4 cell at virological failure, mean ± SD, % 7.7 ± 5.1
Plasma HIV-1 RNA at virological failure, median (IQR), copies/mL 55,800
(9,670-100,000)
   Log, copies/mL 4.8 (4.0-5.0)
Total cholesterol, mean ± SD, mg/dL 165 ± 42
HDL choleterol, mean ± SD, mg/dL 41 ± 30
Triglyceride, mean ± SD, mg/dL 172 ± 117
Total cholesterol:HDL ratio ≥6.5, number (%) 2 (5)
Fasting blood sugar, mean ± SD, mg% 100 ± 27
Patients with ≥3 TAMs, number (%) 13 (32.5%)
Patients with Q151M, number (%) 7 (18%)